[ad_1]
The opioid market research report forecast for 2018-2026 is an important source of relevant data for market strategists. It presents the overview of the opioid drug industry with the analysis of growth and past and future data on costs, revenues, demand and supply (where applicable ). Research analysts present a detailed representation of the value chain and its analysis of distributors. This opioid drug market study provides comprehensive data that improves understanding.
Search here for the full report:
https://www.credenceresearch.com/report/opioid-drugs-market
Market overview:
Opioids are a promising pharmaceutical class with a major application in pain management. Opioid medications help relieve pain by binding to opioid receptors on the nervous system. Opioid medications not only have a promising effect in relieving pain, suppressing coughing and as an anesthetic agent, but also in treating diarrhea, opioid-related disorders and reversing the effects. overdoses of opioids. However, the side effects associated with opioid medications, opioid abuse and addiction have affected the overall market for opioid medications.
Opioids have a huge medical application in the treatment of pain associated with cancer, AIDS and arthritis; the increasing global prevalence of these diseases is fueling the growth of the opioid drug market. The increasing trend of surgeries subsequently increases the use of opioid medications both in the treatment of surgical pain and as anesthetic agents. However, the increase in opioid abuse and addiction has led to unethical sales of opioid drugs; Serious health problems caused by opioid overdose and addiction have attracted the attention of the health care administration. As a result, strict regulatory guidelines on the use of opiates are expected to hinder the rapid growth of the opioid drug market. Recently, the FDA ordered Endo Pharmaceuticals to withdraw the Opano ER long-acting opioid drug from the marketplace. Strict regulations are expected in the near future due to public health concerns.
Arymo ER and Vantrela and RoxyBond are marketed as the first and only immediate-release opioid analgesics whose label could have a deterrent effect on abuse. This growing trend toward safer drug approvals and a robust pipeline portfolio is expected to drive continued market growth. In addition, the infiltration of non-opioid drugs into the market is more important than the opioid preference because of the increasing rate of reported opioid overdose deaths.
Based on different types of opioid drugs, the market is segmented into morphine, methadone, codeine, oxycodone, meperidine and fentanyl. Morphine and codeine collectively strengthen the overall growth of the opioid drug market with effective results in pain management and cough suppression. Based on opioid drug applications, it is estimated that the pain management segment generates maximum income due to the increasing prevalence of chronic pain, which is the leading cause of physical disability worldwide.
Geographically, the global opioid drug market is segmented into North America, Europe, Asia-Pacific, Latin America, the Middle East and Africa. With respect to the current scenario, North America is the dominant region in the global opioid market due to the growing prevalence of cancer and chronic pain. The maximum consumption of prescription and over-the-counter opioid medications and the growing epidemic of opioid dependence have made North America the largest regional market followed by Europe. The Asia-Pacific is expected to experience significant growth due to the market boom in China and the emerging development of health care.
Scope
Analysis of trends in the global opioid drug industry and interest in opioid drugs in various regions, including Asia-Pacific, Europe and North America
Size and value of the opioid market used for commercial opioid drugs from 2011 to 2017 and forecasts for eight years up to 2026
The qualitative study of the factors and limits of the opiate drugs market
Information on key market players such as BASF, Clariant, Cytec, SNF FloMin, Beijing Hengju Chemical Group and Kemira, among others.
Reasons to buy
Updated report and update on the global market for opioid drugs
Recognize key regions and countries that describe potential growth opportunities for the opioid drug market
Facilitate decision-making by understanding the opportunities offered by the opioid drug market
Obtain information on the main players in the opiate drugs market
Request an example of a free report:
https://www.credenceresearch.com/sample-request/58852
Research methodology and delivery time
Credence Research has conducted extensive secondary research to obtain key information. Data collected from key public sector sources and publications were digitized and analyzed in an unbiased manner to present a clear picture of the sector. All recent developments impacting the dynamics of the sector have been captured and used to support the research hypothesis.
The report is available in the form of a single-site single-user license. The delivery time for the electronic version of the report is 3 working days, each copy being subject to a thorough quality control and updated with the latest information available.
about us
Credence Research is a global market research and advisory firm serving leadership organizations, governments, non-legislative associations and non-profit organizations. We provide our customers with assistance to make lasting improvements to their execution and to understand their most imperative goals. In almost a century, we have built a company extraordinarily prepared for this task.
Contact us:
Credence Research Inc.
105 N 1st ST # 429
SAN JOSE, CA 95103, United States
Email: [email protected]
Source link
